Loading…
Saving Us from Pandemic Era Resistance by Building a Unified Global Strategy Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Saving Us from Pandemic Era Resistance by Building a Unified Global Strategy Act of 2021 or the SUPER BUGS Act of 2021 This bill requires the Department of Health and Human Services (HHS) to seek to enter into agreements with foreign countries to develop and commercialize new drugs to address pandemics. HHS shall report to Congress a strategy for achieving this goal.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
(H.R.8205 / S.4472) Reauthorization and fully funding of the ACT for ALS (Public Law 117-79) for continued access to promising treatments and research. (S.925/H.R.2036) Credit for Caring Act to provide relief in the form of a new, non-refundable federal tax credit for eligible working family caregivers. (S.1261/H.R.4206) The CONNECT for Health Act to expand coverage of telehealth services through Medicare and make it easier for ALS patients to connect with their doctors. (S.3763/H.R.7336) ALS Better Care Act to amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes. (H.R.7779) HEALTHY BRAINS Act to amend the Public Health Service Act to require the Secretary of Health and Human Services to establish a program for the conduct and support of research, training, and health information dissemination with respect to environmental risk factors of neurodegenerative diseases, and for other purposes. Regulatory flexibility at FDA for expedited pathways to promising treatments for ALS patients because the standard drug approval process (12-14 years) takes too long for people with rapidly progressive terminal conditions with no substantial therapies.
Referred to the House Committee on Foreign Affairs.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $40,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
(H.R.8205 / S.4472) Reauthorization and fully funding of the ACT for ALS (Public Law 117-79) for continued access to promising treatments and research. (S.925/H.R.2036) Credit for Caring Act to provide relief in the form of a new, non-refundable federal tax credit for eligible working family caregivers. (S.1261/H.R.4206) The CONNECT for Health Act to expand coverage of telehealth services through Medicare and make it easier for ALS patients to connect with their doctors. (S.3763/H.R.7336) ALS Better Care Act to amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes. (H.R.7779) HEALTHY BRAINS Act to amend the Public Health Service Act to require the Secretary of Health and Human Services to establish a program for the conduct and support of research, training, and health information dissemination with respect to environmental risk factors of neurodegenerative diseases, and for other purposes. Regulatory flexibility at FDA for expedited pathways to promising treatments for ALS patients because the standard drug approval process (12-14 years) takes too long for people with rapidly progressive terminal conditions with no substantial therapies.
Client expense: $30,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
(H.R.8205) Reauthorization and fully funding of the ACT for ALS (Public Law 117-79) for continued access to promising treatments and research. (S.925/H.R.2036) Credit for Caring Act to provide relief in the form of a new, non-refundable federal tax credit for eligible working family caregivers. (S.1261/H.R.4206) The CONNECT for Health Act to expand coverage of telehealth services through Medicare and make it easier for ALS patients to connect with their doctors. (S.3763/H.R.7336) ALS Better Care Act to amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes. (H.R.7779) HEALTHY BRAINS Act to amend the Public Health Service Act to require the Secretary of Health and Human Services to establish a program for the conduct and support of research, training, and health information dissemination with respect to environmental risk factors of neurodegenerative diseases, and for other purposes. Regulatory flexibility at FDA for expedited pathways to promising treatments for ALS patients because the standard drug approval process (12-14 years) takes too long for people with rapidly progressive terminal conditions with no substantial therapies.
Client expense: $30,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Reauthorization and fully funding of the ACT for ALS (Public Law 117-79) for continued access to promising treatments and research. (S.925/H.R.2036) Credit for Caring Act to provide relief in the form of a new, non-refundable federal tax credit for eligible working family caregivers. (S.1261) The CONNECT for Health Act to expand coverage of telehealth services through Medicare and make it easier for ALS patients to connect with their doctors. Regulatory flexibility at FDA for expedited pathways to promising treatments for ALS patients because the standard drug approval process (12-14 years) takes too long for people with rapidly progressive terminal conditions with no substantial therapies.
Client expense: $30,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Reauthorization and fully funding of the ACT for ALS (Public Law 117-79) for continued access to promising treatments and research. (S.925/H.R.2036) Credit for Caring Act to provide relief in the form of a new, non-refundable federal tax credit for eligible working family caregivers. (S.1261) The CONNECT for Health Act to expand coverage of telehealth services through Medicare and make it easier for ALS patients to connect with their doctors. Regulatory flexibility at FDA for expedited pathways to promising treatments for ALS patients because the standard drug approval process (12-14 years) takes too long for people with rapidly progressive terminal conditions with no substantial therapies.
Client expense: $20,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Medical/Disease Research/Clinical Labs
Antimicrobial resistance; Antibiotic research and development; Pandemic preparedness as it relates to antimicrobial resistance; S. 2076, H.R. 3932 - PASTEUR Act; H.R. 2036 - Saving Us from Pandemic Era Resistance by Building a Unified Global Strategy Act of 2021.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Medical/Disease Research/Clinical Labs
Antimicrobial resistance; Antibiotic research and development; Pandemic preparedness as it relates to antimicrobial resistance; S. 2076, H.R. 3932 - PASTEUR Act; H.R. 2036 - Saving Us from Pandemic Era Resistance by Building a Unified Global Strategy Act of 2021.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE